Home > Cardiology > VTE readmission risk extends beyond 30 days after complex cancer surgery

VTE readmission risk extends beyond 30 days after complex cancer surgery


Notice: Undefined index: new_doi_fields in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/template-parts/content-structured.php on line 22

Notice: Trying to access array offset on value of type null in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/template-parts/content-structured.php on line 22

Notice: Trying to access array offset on value of type null in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/template-parts/content-structured.php on line 22
Journal
JAMA Surgery
Reuters Health - 03/02/2022 - The risk of a venous thromboembolism (VTE)-related hospital readmission is increased well beyond 30 days after complex cancer surgery, a cohort study shows. "Although the majority of complications occur within 30 days, this is an arbitrarily chosen cutoff," Dr. Syed Nabeel Zafar of the University of Wisconsin School of Medicine and Public Health and colleagues write in JAMA Surgery. "There are no data to suggest a sudden decline in VTE risk at the 30-day mark." "We demonstrate that the risk is different depending on procedure performed, and... that this risk extends beyond the 30 days ... for several surgery subtypes," Dr. Zafar told Reuters Health by email. "While the proportion of patients having a clinical relevant VTE event is overall small, the consequences are high," he said. "The burden of readmissions due to VTE is high in terms of patient morbidity, days in the hospital, and also cost to the health care system." "...


Please login to read the full text of the article.


If you have no account yet, please register now.





Posted on